Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study of VI-0521 in Obese Adolescents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors VIVUS
- 18 Dec 2019 Results presented in a VIVUS Media Release.
- 18 Dec 2019 According to a VIVUS media release, data were published online in Diabetes, Obesity and Metabolism.
- 30 Nov 2016 Status changed from active, no longer recruiting to completed.